The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus
Open accessAbstract
A pandemic of a novel Coronavirus emerged in December of 2019 (COVID-19), causing devastating public health impact across the world. In the absence of a safe and effective vaccine or antivirals, strategies for con- trolling and mitigating the burden of the pandemic are focused on non-pharmaceutical interventions, such as social-distancing, contact-tracing, quarantine, isolation and the use of face-masks in public. We develop a new mathematical model for assessing the population-level impact of the aforementioned control and mitigation strategies. Rigorous analysis of the model shows that the disease-free equilibrium is locally-asymptotically stable if a certain epidemiological threshold, known as the reproduction number (denoted by Rc), is less than unity. This equilibrium is globally-asymptotically stable, for a special case of the model where quarantined-susceptible individuals do not acquire COVID-19 infection during quarantine, when Rc is less than unity. The epidemiological consequence of this theoretical result is that, the community-wide implementation of control interventions that can bring (and maintain) Rc to a value less than unity will lead to the effective control (or elimination) of COVID-19 in the community. Simulations of the model, using data relevant to COVID-19 transmission dynamics in the US state of New York and the entire US, show that the pandemic burden will peak in mid and late April, respectively. The worst-case scenario projections for cumulative mortality (based on baseline levels of interventions) are 105, 100 for New York state and 164, 000 for the entire US by the end of the pandemic. These numbers dramatically decreased by 80% and 64%, respectively, if adherence to strict social-distancing measures is improved and maintained until the end of May or June. The duration and timing of the relaxation or termination of the strict social-distancing measures are crucially important in determining the future trajectory of the COVID-19 pandemic. This study shows that early termination of the strict social-distancing measures could trigger a devastating second wave with burden similar to those projected before the onset of the strict social-distance measures were implemented. The use of efficacious face-masks (such as surgical masks, with estimated efficacy ≥ 70%) in public could lead to the elimination of the pandemic if at least 70% of the residents of New York state use such masks in public consistently (nationwide, a compliance of at least 80% will be required using such masks). The use of low efficacy masks, such as cloth masks (of estimated efficacy less than 30%), could also lead to significant reduction of COVID-19 burden (albeit, they are not able to lead to elimination). Combining low efficacy masks with improved levels of the other anti-COVID-19 intervention strategies can lead to the elimination of the pandemic. This study emphasizes the important role social-distancing plays in curtailing the burden of COVID-19. Increases in the adherence level of social-distancing protocols result in dramatic reduction of the burden of the pandemic, and the timely implementation of social-distancing measures in numerous states of the US may have averted a catastrophic outcome with respect to the burden of COVID-19. Using face-masks in public (including the low efficacy cloth masks) is very useful in minimizing community transmission and burden of COVID-19, provided their coverage level is high. The masks coverage needed to eliminate COVID-19 decreases if the masks-based intervention is combined with the strict social-distancing strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
A contribution to the mathematical theory of epidemics
Kermack, W. O., & McKendrick, A. G. (1927) · Proceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character · doi:10.1098/rspa.1927.0118 · Cited by 11,701
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
van den Driessche, P., & Watmough, J. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00108-6 · Cited by 9,977
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Diekmann, O., Heesterbeek, J. A. P., & Metz, J. A. J. (1990) · Journal of Mathematical Biology · doi:10.1007/bf00178324 · Cited by 5,091
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
Early dynamics of transmission and control of COVID-19: a mathematical modelling study
Kucharski, A. J., Russell, T. W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., Eggo, R. M., Sun, F., Jit, M., Munday, J. D., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30144-4 · Cited by 2,671
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts
Hellewell, J., Abbott, S., Gimma, A., Bosse, N. I., Jarvis, C. I., Russell, T. W., Munday, J. D., Kucharski, A. J., Edmunds, W. J., Sun, F., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30074-7 · Cited by 2,550
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing
Wang, C. J., Ng, C. Y., & Brook, R. H. (2020) · JAMA · doi:10.1001/jama.2020.3151 · Cited by 1,391
Tang, B., Wang, X., Li, Q., Bragazzi, N. L., Tang, S., Xiao, Y., & Wu, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020462 · Cited by 1,368
Eikenberry, S. E., Mancuso, M., Iboi, E., Phan, T., Eikenberry, K., Kuang, Y., Kostelich, E., & Gumel, A. B. (2020) · Infectious Disease Modelling · doi:10.1016/j.idm.2020.04.001 · Cited by 1,343
Self-citationSpread of SARS-CoV-2 in the Icelandic population
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006100 · Cited by 1,248
Characteristics of COVID-19 infection in Beijing
Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., Chen, H., Wang, D., Liu, N., Liu, D., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.018 · Cited by 1,231
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., Dai, J., Sun, Q., Zhao, F., Qu, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.016 · Cited by 989
The effect of public health measures on the 1918 influenza pandemic in U.S. cities
Bootsma, M. C. J., & Ferguson, N. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611071104 · Cited by 798
COVID-19—New Insights on a Rapidly Changing Epidemic
del Rio, C., & Malani, P. N. (2020) · JAMA · doi:10.1001/jama.2020.3072 · Cited by 756
Cowling, B. J., Chan, K.-H., Fang, V. J., Cheng, C. K. Y., Fung, R. O. P., Wai, W., Sin, J., Seto, W. H., Yung, R., Chu, D. W. S., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00142 · Cited by 533
Testing the Efficacy of Homemade Masks: Would They Protect in an Influenza Pandemic?
Davies, A., Thompson, K.-A., Giri, K., Kafatos, G., Walker, J., & Bennett, A. (2013) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2013.43 · Cited by 498
Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures
World Health Organization Writing Group (2012) · Emerging Infectious Diseases · doi:10.3201/eid1201.051371 · Cited by 470
Face mask use and control of respiratory virus transmission in households
MacIntyre, C. R., Cauchemez, S., Dwyer, D. E., Seale, H., Cheung, P., Browne, G., Fasher, M., Wood, J., Gao, Z., Booy, R., et al. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1502.081166 · Cited by 461
Self-citationvan der Sande, M., Teunis, P., & Sabel, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002618 · Cited by 458
IHME COVID-19 health service utilization forecasting team, & Murray, C. J. (2020) · medRxiv · doi:10.1101/2020.03.27.20043752 · Cited by 417
Aiello, A. E., Murray, G. F., Perez, V., Coulborn, R. M., Davis, B. M., Uddin, M., Shay, D. K., Waterman, S. H., & Monto, A. S. (2010) · The Journal of Infectious Diseases · doi:10.1086/650396 · Cited by 354
SARS Transmission, Risk Factors, and Prevention in Hong Kong
Lau, J. T. F., Tsui, H., Lau, M., & Yang, X. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1004.030628 · Cited by 338
Mizumoto, K., & Chowell, G. (2020) · Infectious Disease Modelling · doi:10.1016/j.idm.2020.02.003 · Cited by 313
Facemasks, Hand Hygiene, and Influenza among Young Adults: A Randomized Intervention Trial
Aiello, A. E., Perez, V., Coulborn, R. M., Davis, B. M., Uddin, M., & Monto, A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029744 · Cited by 212
Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China
Wu, J., Xu, F., Zhou, W., Feikin, D. R., Lin, C.-Y., He, X., Zhu, Z., Liang, W., Chin, D. P., & Schuchat, A. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030730 · Cited by 173
When Is Quarantine a Useful Control Strategy for Emerging Infectious Diseases?
Day, T., Park, A., Madras, N., Gumel, A., & Wu, J. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj056 · Cited by 168
Self-citationFirst imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia
Silverstein, W. K., Stroud, L. F., Cleghorn, G., & Leis, J. A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30370-6 · Cited by 147
Final and peak epidemic sizes for SEIR models with quarantine and isolation
Feng, Z., & Feng, Z. (2007) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2007.4.675 · Cited by 130
Safi, M. A., & Gumel, A. B. (2011) · Computers & Mathematics with Applications · doi:10.1016/j.camwa.2011.03.095 · Cited by 84
Self-citationInfluenza pandemics: a historical retrospect
Tognotti, E. (2009) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.239 · Cited by 42
The Final Size of a Serious Epidemic
Brauer, F. (2018) · Bulletin of Mathematical Biology · doi:10.1007/s11538-018-00549-x · Cited by 36
Driessche, K. V., Hens, N., Tilley, P. A. G., Quon, B. S., Chilvers, M. A., de Groot, R., Cotton, M. F., Marais, B. J., Speert, D. P., & Zlosnik, J. E. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0481le · Cited by 23
To mask or not to mask: a note on the 1918 Spanish influenza epidemic in Tucson.
Luckingham, B. (1984) · PubMed · Cited by 21
An Historical Antecedent of Modern Guidelines for Community Pandemic Influenza Mitigation
Morens, D. M., Taubenberger, J. K., Folkers, G. K., & Fauci, A. S. (2009) · Public Health Reports · doi:10.1177/003335490912400105 · Cited by 18
Cited by
An evidence review of face masks against COVID-19
Howard, J., Huang, A., Li, Z., Tufekci, Z., Zdimal, V., van der Westhuizen, H.-M., von Delft, A., Price, A., Fridman, L., Tang, L.-H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014564118 · Cited by 1,529
COVID-19 and Public Transportation: Current Assessment, Prospects, and Research Needs
Tirachini, A., & Cats, O. (2020) · Journal of Public Transportation · doi:10.5038/2375-0901.22.1.1 · Cited by 781
Modeling COVID-19 scenarios for the United States
IHME COVID-19 Forecasting Team, Reiner, R. C., Barber, R. M., Collins, J. K., Zheng, P., Adolph, C., Albright, J., Antony, C. M., Aravkin, A. Y., Bachmeier, S. D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1132-9 · Cited by 556
Non-pharmaceutical interventions during the COVID-19 pandemic: A review
Perra, N. (2021) · Physics Reports · doi:10.1016/j.physrep.2021.02.001 · Cited by 531
Impact of community masking on COVID-19: a cluster-randomized trial in Bangladesh
Abaluck, J., Kwong, L. H., Styczynski, A., Haque, A., Kabir, M. A., Bates-Jefferys, E., Crawford, E., Benjamin-Chung, J., Raihan, S., Rahman, S., et al. (2022) · Science · doi:10.1126/science.abi9069 · Cited by 333
Metadata
- Authors
- Ngonghala, C. N., Iboi, E., Eikenberry, S., Scotch, M., MacIntyre, C. R., Bonds, M. H., & Gumel, A. B.
- Venue
- Mathematical Biosciences
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 325
- Pages
- 108364
- ISSN
- 0025-5564 (ISSN-L)
- OpenAlex
- W3016443614
- Cited by
- 549
- References
- 45
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.